Eli Lilly licenses early-stage non-opioid pain drug from Belgian biotech Confo
Eli Lilly has licensed a Phase I non-opioid pain candidate from Confo Therapeutics, adding to the handful of pain drugs the pharma company is trying …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
